Clinical efficacy of traditional chinese medicine on acute myocardial infarction—A prospective cohort study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To evaluate the clinical effects of Chinese medicine (CM) on acute myocardial infarction (AMI) with a prospective cohort study.
A total of 334 AMI patients from January 2007 to March 2009 were consecutively enrolled, and were assigned to a treatment group (169 cases) treated with combined therapy (CM for at least one month and Western medicine) and a control group (165 cases) with Western medicine alone. Clinical data including age, gender, smoking, medical history, infarction area, heart functional classification, CM syndrome scores, blood-stasis syndrome score, primary end-point (death, nonfatal myocardial infarction, and revascularization) and secondary end-point (ischemic stroke, rehospitalization due to angina, heart failure and shock), were collected. CM syndrome scores, blood-stasis syndrome score, primary end-point and secondary end-point were collected during the 6-month follow-up. Kaplan-Meier method was used for the survival analysis. The multifactor analysis was analyzed by Cox proportional hazards regression.
At the end of 6-month the CM syndrome score and bloodstasis syndrome score in the treatment group were lower than those in the control group (P<0.01), especially the symptoms of chest pain, spontaneous perspiration and insomnia. Rehospitalization rate due to angina during the 6-month follow-up in the treatment group (2.96%) was lower than that in the control group (7.88%, P<0.05). Kaplan- Meier survival curve showed that event-free cumulated survival of rehospitalization due to angina during the 6-month follow-up in the treatment group was higher than that in the control group (Log rank 4.700, P=0.03). Cox regression analysis showed that heart dysfunction [hazard ratio (HR)=1.601, 95% CI=1.084–2.364, P=0.018] and diabetes mellitus (HR=1.755, 95% CI=1.031–2.989, P=0.038) were hazard factors to end-point, whereas CM (HR 0.405, 95% CI=0.231–0.712, P=0.002), percutaneous coronary intervention (PCI, HR=0.352, 95% CI=0.204–0.607, P<0.001) and angiotensin converting enzyme (ACE) inhibitors (HR=0.541, 95% CI=0.313–0.936, P=0.028) were protective factors.
CM therapy could decrease CM syndrome scores and blood-stasis syndrome score, reduce the rehospitalization rate during 6-month follow-up due to angina. Heart dysfunction and diabetes mellitus were hazard factors to end-point, whereas CM, PCI and ACE inhibitors were protective factors.
- Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093–1104. CrossRef
- Xiyuan Hospital. The “Anti-infarct Mixture” for acute myocardial infarction—clinical analysis of 118 cases. Chin J Intern Med (Chin) 1976;1:212–215.
- Yin HJ, Wang XG, Shi DZ. Effects of GSTT on release of TNF-α and IL-1β in rats with myocardial ischemia reperfusion injury. Med J Chin PLA (Chin) 2006;31:986–987.
- Shang LZ, Wei DW, Wang F. Effects of ligustrazine on expression of HSP25 and p38MAPK proteins in rats with myocardial ischemia reperfusion injury. China J Tradit Chin Med Pharm (Chin) 2008;23:882–884.
- Li YQ, Jin M, Qiu SL, Zhu TG, Bian H, Wang CL, et al. Effects of Chinese herbal medicine for benefiting qi and nourishing yin to promote blood circulation on ventricular wall motion of AMI patients after revascularization. Chin J Integr Tradit West Med (Chin) 2009;29:300–304.
- Lu XY, Shi DZ, Xu H, Chen KJ, Lu SZ, et al. Clinical study on effect of Xiongshao Capsule on restenosis after percutaneous coronary intervention. Chin J Integr Tradit West Med (Chin) 2006;26:13–16.
- Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Guide to diagnosis and treatment of acute myocardial infarction in China. Chin J Cardiol (Chin) 2001;29:710–725.
- Cardiovascular Institute of Traditional Chinese Medicine Professional Committee. Diagnostic criteria for coronary heart disease. Chin J Integr Tradit West Med (Chin) 1991;11:257–260.
- National Standards for Chinese medicine Industry of People’s Republic of China, Chinese medicine Syndrome. Clinic terminology of traditional Chinese medical diagnosis and treatment—Syndromes (GB/T l6751. 2-1997).
- Professional Committee of Blood Circulation Research, Chinese Association of Integrative Medicine. Diagnosis standard of blood stasis synrome. Chin J Integr Tradit West Med (Chin) 1987;7:129–131.
- Wang J. Study on diagnostic criteria of blood stasis syndrome. Research and clinical application of promoting blood circulation and removing blood stasis. Beijing: Beijing Medical University and Peking Union Medical College Press; 1993:7.
- Qiu SL, Jin M, Zhu TG, Quan X, Liang Y, Shi DZ, et al. Effect of replenishing qi and nourishing yin to promote the blood circulation on 103 patients with acute myocardial infarction after reperfusion. J Capit Med Univ (Chin) 2009;30:426–429.
- Chen KJ, Shi DZ, Xu H, Lu SZ, Li TC, Ke YN, et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chin Med J 2006;119:6–13.
- Duan WH, Li LZ, Wang CL, Gao ZY, Shi DZ, et al. Study on correlation between heart function and Chinese medicine syndrome distribution of acute myocardial infarction. Beijing J Tradit Chin Med (Chin) 2010;29:4–6.
- Lin Q, Nong YB, Duan WH. Retrospective study on influence of Chinese herbal drugs on long-term prognosis of acute myocardial infarction. J Beijing Univ Tradit Chin Med (Chin) 2006;29:419–421.
- Ryo K, Nobuhisa H, Hiroshi K, Yukio Tsurumi, Hiroshi Ogawa, et al. Primary percutaneous coronary intervention vs conservative treatment for acute ST elevation myocardial infarction: short- and long-term follow-up according to disease severity. Circ J 2008;72:1391–1396. CrossRef
- Clinical efficacy of traditional chinese medicine on acute myocardial infarction—A prospective cohort study
Chinese Journal of Integrative Medicine
Volume 18, Issue 11 , pp 807-812
- Cover Date
- Print ISSN
- Online ISSN
- Chinese Association of Traditional and Western Medicine
- Additional Links
- acute myocardial infarction
- Chinese medicine
- survival analysis
- cohort study
- Industry Sectors
- Author Affiliations
- 1. Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China